FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a supplemental application to allow Prasco Laboratories to market aliskiren hemifumarate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN HEMIFUMARATE)